ROUNDTABLE

Exploring options for POP treatment: Patient selection, surgical approaches, and ways to manage risks

Author and Disclosure Information

 

References

Dr. Ridgeway: Women feel very strongly about risk. Within the same clinic I will have similar patients, and I say, “Probably in the long term this one may last a little longer but the surgery takes longer and it has a little higher complication rate.” One patient will say, “I’m not worried about the risk, I want what’s going to last the longest,” whereas a very similar patient will say, “Why would anyone pick the higher-risk operation? I want the lower risk that probably will last a long time.”

Dr. Gebhart: Beri, who should not have a hysteropexy?

Dr. Ridgeway: The biggest factor would be someone who has ever had postmenopausal bleeding. From our data, we know that if they have even had a work-up with benign results, the risk of unanticipated pathology is high. I do not recommend hysteropexy for anyone who has had postmenopausal bleeding.

For a premenopausal woman who has irregular bleeding, I also do not recommend it, because you just do not know what that future will hold. If a patient has anatomic abnormalities like large fibroids, I would not recommend it either. I would like patients to have had standard cervical cancer screening without any abnormalities for about 10 years or so.

Dr. Gebhart: What about prior cervical dysplasia?

Dr. Ridgeway: If a patient had ASCUS or low-grade dysplasia decades ago, has been normal for at least 10 years, and is currently negative for human papillomavirus, I have no problem.

Dr. Gebhart: How about women at high genetic risk for cancer?

Dr. Ridgeway: If they are at high risk for endometrial cancer, I would not recommend hysteropexy. If they are going to need an oophorectomy and/or salpingectomy for risk reduction during prolapse treatment, I usually perform a hysterectomy.

Plan surgical steps and prepare for “what if’s”

Dr. Gebhart: What tips can you provide, either regarding the evaluation or something you do surgically, that are important in a transvaginal native tissue repair?

Dr. Karram: If you have a case of posthysterectomy apical prolapse, that you think is an indication for sacrocolpopexy, in reality these are very good candidates for either sacrospinous or uterosacral suspensions. I prefer a uterosacral suspension as I feel there is less distortion of the vaginal apex compared to a sacrospinous suspension.

Dr. Ridgeway: The most critical step is setting up the OR and positioning the patient. That sets up the case for success, preventing struggles during the case. I use a high lithotomy, with careful positioning of course, but I use candy cane stirrups so that I can have an instrument stand in front of me and not struggle during the case.

Dr. Walters: My tip for everyone who is doing native tissue surgery, whether it is high McCall colpopexy or uterosacral ligament suspension or sacrocolpopexy, would be to really learn well the anatomy of each operation, including how close the ureter is, where the risk for bleeding is, and where the risk for nerve damage is.

The complications for each of these surgeries are slightly different, but there is a small risk of kinking the ureter with both uterosacral ligament suspension and the McCall, so you should do a cystoscopy as part of that operation. If you do a sacrospinous ligament suspension, use an instrument that can get a stitch into a ligament—not too close to the ischial spine and not too close to the sacrum—to avoid the risk of damage to major nerves and blood vessels and to minimize buttock and leg pain.

Continue to: Another tip is to understand...

Pages

Recommended Reading

The mesh mess, enmeshed in controversy
MDedge ObGyn
Native tissue repair of POP: Surgical techniques to improve outcomes
MDedge ObGyn
2019 Update on pelvic floor dysfunction
MDedge ObGyn
Native tissue repair of POP: Apical suspension, anterior repair, and posterior repair
MDedge ObGyn
A novel approach to complete transobturator sling mesh removal
MDedge ObGyn
Using slings for the surgical management of urinary incontinence: A safe, effective, evidence-based approach
MDedge ObGyn
Medical management of abnormal uterine bleeding in reproductive-age women
MDedge ObGyn
Can the office visit interval for routine pessary care be extended safely?
MDedge ObGyn
Product update: Neuromodulation device, cystoscopy simplified, hysteroscopy seal, next immunization frontier
MDedge ObGyn
Consider sparing the uterus in prolapse procedures
MDedge ObGyn